Many of the children were eligible for federal aid, experts said, but errors have been common as states “unwind” assistance from earlier in the coronavirus pandemic.
Category: Federal-State Relations (US)
-
A ‘Shadow’ Lending Market in the U.S., Funded by Insurance Premiums
Apollo was the first to use annuities to build a major financing business. Others followed, driving the growth of the private lending market and worrying regulators.
-
Federal Court Says Consumer Watchdog Can’t Check Banks for Discrimination
A Texas judge’s sweeping ruling says the Consumer Financial Protection Bureau exceeded its authority in trying to examine banks for uneven treatment.
-
Could U.S. Toughness on Chinese Business Have Unintended Consequences?
Businesses fear that efforts to look tough on Beijing, which have the potential to be more expansive than moves by the federal government, could have unintended consequences.
-
Air Taxis, Hyped for Years, May Finally Arrive by 2028
Federal regulators released a plan that would allow a new generation of small aircraft to transport people short distances.
-
Blocked Rail Crossings Snarl Towns, but Congress Won’t Act
The industry has used its muscle to prevent federal, state and local governments from penalizing companies that park freight trains across roads for hours or days.
-
When Trains Block a Road, Local Officials Have Few Options
The federal government has begun offering $3 billion for bridges and tunnels, but many local governments say they cannot take advantage of the money.
-
Can the ‘California Effect’ Survive in a Hyperpartisan America?
For decades the state has been setting policy for the whole nation. Now red states are pushing back.
-
Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market
The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.
-
Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority
Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.
-
Health Plans No Longer Have to Cover All Preventive Care at No Cost. Here’s What to Know.
The New York Times – Business:A ruling by a federal judge this week could set up yet another Supreme Court challenge to the Obamacare health law.
-
New Lawsuit Challenges State Bans on Abortion Pills
The New York Times – Business:The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.